Search results
Results From The WOW.Com Content Network
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing"; pl.: prognoses) is a medical term for predicting the likelihood or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and ...
Survival rate is a part of survival analysis.It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be used for the assessment of standards of therapy.
Terminal illness or end-stage disease is a disease that cannot be cured or adequately treated and is expected to result in the death of the patient. This term is more commonly used for progressive diseases such as cancer, rather than fatal injury.
The prognosis is very positive since the cancer is at stage 0, meaning treatment will be less invasive and more effective, with a survival rate of 99%, according to the National Breast Cancer ...
A prognostic variable in engineering within the context of prognostics, is a measured or estimated variable that is correlated with the health condition of a system, and may be used to predict its residual useful life.
Data-driven prognostics usually use pattern recognition and machine learning techniques to detect changes in system states. [3] The classical data-driven methods for nonlinear system prediction include the use of stochastic models such as the autoregressive (AR) model, the threshold AR model, the bilinear model, the projection pursuit, the multivariate adaptive regression splines, and the ...
The International Prognostic Index (IPI) is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive non-Hodgkin's lymphoma. Previous to IPI's development, the primary consideration in assessing prognosis was the Ann Arbor stage alone, but this was increasingly found to be an inadequate means of ...
A panel of epigenetic methylation marker has been explored for prognosis of ovarian cancer, and it is reported that the panel exhibited high specificity and sensitivity (both above 70%) as a screen marker. [5] Epigenetic markers have also shown promising potential as prognostic markers for bladder cancer. [6]